BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

943 related articles for article (PubMed ID: 23217877)

  • 1. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan.
    Kinoshita Y; Suminoe A; Inada H; Yagi M; Yanai F; Zaizen Y; Nishi M; Inomata Y; Kawakami K; Matsufuji H; Suenobu S; Handa N; Kohashi K; Oda Y; Hara T; Taguchi T
    J Pediatr Surg; 2012 Dec; 47(12):2205-9. PubMed ID: 23217877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
    Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
    J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and outcome of Wilms tumors with a favorable histology in Japan: a report from the Study Group for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan.
    Suita S; Kinoshita Y; Tajiri T; Hara T; Tsuneyoshi M; Mizote H; Inada H; Takamatsu H; Kawano Y; Inomata Y; Nagasaki A; Ono Y; Handa N; Okamura J; Ishii E; Kawakami K;
    J Pediatr Surg; 2006 Sep; 41(9):1501-5. PubMed ID: 16952581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nephroblastomas (Wilms' tumors) and special variations of nephroblastomas].
    Schmidt D
    Veroff Pathol; 1989; 133():1-174. PubMed ID: 2556868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blastemal predominant type Wilms tumor in Japan: Japan Children's Cancer Group.
    Koshinaga T; Takimoto T; Okita H; Tanaka Y; Inoue E; Oue T; Nozaki M; Tsuchiya K; Haruta M; Kaneko Y; Fukuzawa M
    Pediatr Int; 2019 Apr; 61(4):351-357. PubMed ID: 30786111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of advanced Wilms' tumor].
    Li MJ; Huang Y; Tang DX; Zhou YB; Tang HF; Liang JF
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):791-5. PubMed ID: 17366799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical aspects in the treatment of patients with unilateral wilms tumor: a report from the SIOP 93-01/German Society of Pediatric Oncology and Hematology.
    Fuchs J; Kienecker K; Furtwängler R; Warmann SW; Bürger D; Thürhoff JW; Hager J; Graf N
    Ann Surg; 2009 Apr; 249(4):666-71. PubMed ID: 19300220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current therapy for Wilms' tumor.
    Metzger ML; Dome JS
    Oncologist; 2005; 10(10):815-26. PubMed ID: 16314292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognosis of prechemotherapy blastemal predominant histology subtype in Wilms tumor: A retrospective study in China.
    Huang J; Zhang Y; Zhen Z; Lu S; Zhu J; Wang J; Sun F; Liu Z; Gao Y; Li H; Zhang Y; Sun X
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28567. PubMed ID: 32813315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of disease classified as stage III in Wilms tumor: a report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
    Spreafico F; Gandola L; D'Angelo P; Terenziani M; Collini P; Bianchi M; Provenzi M; Indolfi P; Pession A; Nantron M; Di Cataldo A; Marchianò A; Catania S; Fossati Bellani F; Piva L;
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):348-54. PubMed ID: 21075548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wilms' tumor--single-center experience with renal surgery.
    Seseke F; Zöller G; Ringert RH
    Scand J Urol Nephrol; 2004; 38(5):373-7. PubMed ID: 15764247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.
    Mitchell C; Pritchard-Jones K; Shannon R; Hutton C; Stevens S; Machin D; Imeson J; Kelsey A; Vujanic GM; Gornall P; Walker J; Taylor R; Sartori P; Hale J; Levitt G; Messahel B; Middleton H; Grundy R; Pritchard J;
    Eur J Cancer; 2006 Oct; 42(15):2554-62. PubMed ID: 16904312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral Wilms' tumors: a single-center experience with 19 cases.
    Millar AJ; Davidson A; Rode H; Numanoglu A; Hartley PS; Daubenton JD; Desai F
    J Pediatr Surg; 2005 Aug; 40(8):1289-94. PubMed ID: 16080934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01.
    Graf N; van Tinteren H; Bergeron C; Pein F; van den Heuvel-Eibrink MM; Sandstedt B; Schenk JP; Godzinski J; Oldenburger F; Furtwängler R; de Kraker J
    Eur J Cancer; 2012 Nov; 48(17):3240-8. PubMed ID: 22795263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilms' tumor: a 10 year retrospective study.
    Seyed-Ahadi MM; Khaleghnejad-Tabari A; Mirshemirani A; Sadeghian N; Amonollahi O
    Arch Iran Med; 2007 Jan; 10(1):65-9. PubMed ID: 17198457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcomes in adults with favorable histologic type Wilms tumor-an update from the National Wilms Tumor Study Group.
    Kalapurakal JA; Nan B; Norkool P; Coppes M; Perlman E; Beckwith B; Ritchey M; Breslow N; Grundy P; D'angio GJ; Green DM; Thomas PR
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1379-84. PubMed ID: 15590168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
    Liu WG; Gu WZ; Zhou YB; Tang HF; Li MJ; Ma WX
    Eur J Clin Invest; 2008 Dec; 38(12):931-8. PubMed ID: 19021718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilms' tumor: past, present and (possibly) future.
    Spreafico F; Bellani FF
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):249-58. PubMed ID: 16445377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.